Aadi Bioscience - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsAadi Bioscience

Aadi Bioscience

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Fyarro	Sirolimus	2021-11-22	2029-2040	Kidney transplantation , Lymphangioleiomyomatosis , Perivascular epithelioid cell neoplasms , Graft rejection

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

neoplasm metastasis

,

port-wine stain

,

capillary hemangioma

,

triple negative breast neoplasms

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

t-cell lymphoma peripheral

,

lymphoid leukemia

,

,

,

pancreatic neoplasms

,

,

brain neoplasms

,

,

,

oligodendroglioma

,

tuberous sclerosis

,

,

,

,

,

head and neck neoplasms

,

multiple myeloma

,

colorectal neoplasms

,

squamous cell neoplasms

,

non-small-cell lung carcinoma

,

,

squamous cell carcinoma

,

nasopharyngeal neoplasms

,

multiple hamartoma syndrome

,

,

,

,

kasabach-merritt syndrome

,

hemangioendothelioma

,

hepatocellular carcinoma

,

liver neoplasms

,

chronic kidney failure

,

pulmonary vein stenosis

,

pathologic constriction

,

endometrial neoplasms

,

,

,

thyroid neoplasms

,

thyroid diseases

,

central nervous system neoplasms

,

nervous system neoplasms

,

systemic lupus erythematosus

,

,

renal cell carcinoma

,

,

breast neoplasms

,

kidney neoplasms

,

,

urogenital neoplasms

,

renal insufficiency

,

carotid artery diseases

,

atherosclerosis

,

brain stem infarctions

,

sturge-weber syndrome

,

klippel-trenaunay-weber syndrome

,

cognitive dysfunction

,

kidney transplantation

,

,

non-hodgkin lymphoma

,

mantle-cell lymphoma

,

graft rejection

,

,

gastrointestinal stromal tumors

,

neuroendocrine tumors

,

islet cell adenoma

,

kidney diseases

,

,

atrial fibrillation

,

,

,

non-small-cell lung carcinoma

,

renal insufficiency

,

urologic neoplasms

,

,

breast neoplasms

,

ovarian neoplasms

,

endometrial neoplasms

,

head and neck neoplasms

,

,

,

transitional cell carcinoma

,

unknown primary neoplasms

,

neoplasm metastasis

,

testicular neoplasms

,

ovarian epithelial carcinoma

,

type 2 diabetes mellitus

,

,

hidradenitis suppurativa

,

,

,

,

non-hodgkin lymphoma

,

multiple myeloma

,

,

hodgkin disease

,

mantle-cell lymphoma

,

,

,

ankylosing spondylitis

,

prostatic neoplasms

,

ulcerative colitis

,

juvenile arthritis

,

,

psoriatic arthritis

,

chronic renal insufficiency

,

kidney diseases

,

,

protein-energy malnutrition

,

congenital heart defects

,

premature birth

,

bronchopulmonary dysplasia

,

respiratory syncytial virus infections

,

inflammatory bowel diseases

,

precocious puberty

,

exocrine pancreatic insufficiency

,

,

giant cell arteritis

,

spondylarthritis

,

hypoalbuminemia

,

oxidative stress

,

interstitial cystitis

,

rheumatoid arthritis

,

,

,

,

diabetes mellitus

,

esophageal neoplasms

,

,

coronary artery disease

,

cardiovascular diseases

,

,

,

acquired immunodeficiency syndrome

,

,

human influenza

,

,

,

,

,

stomach neoplasms

,

gastrointestinal stromal tumors

,

,

failed back surgery syndrome

,

,

critical illness

,

enteral nutrition

,

,

hepatocellular carcinoma

,

liver neoplasms

,

influenza b virus

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use